American Vanguard Reports Full Year 2025 Results: Major Changes and Forward-Looking Guidance

Key Financial Highlights

• Net Sales: \$515 million for 2025, down 6% from \$547 million in 2024.
• GAAP Net Loss: \$50 million in 2025, a significant improvement from \$126 million net loss in 2024.
• Adjusted EBITDA: \$39.2 million in 2025, nearly flat versus \$39.1 million in 2024.
• Forecast for 2026: Adjusted EBITDA expected between \$44 million and \$48 million.
• Gross Profit Margin: Improved to 29% in 2025 from 22% in 2024.
• International Sales: Decreased 14% year-over-year, with US sales relatively stable.
• New Credit Facilities: Two new term loans totaling \$285 million, replacing the revolving credit facility, led by Centerbridge Partners and BMO.

Operational and Strategic Initiatives

• Los Angeles Manufacturing Facility Rationalization: The company will significantly reduce activities at its oldest manufacturing facility in Los Angeles, citing lack of competitiveness.
• Corporate Headquarters Move: Relocation from Newport Beach, California, scheduled for mid-2026, expected to yield cost savings.
• Personnel Changes: Restructuring in the management of the commercial team to drive renewed customer-centric focus and improve operational efficiency.
• Product Pipeline: The company plans to launch new products beginning in 2026, aiming for growth and higher profitability.
• ERP Implementation: Completion of global ERP platform rollout in 2026 to enhance operational technology and efficiency.
• Business Improvement Actions: Ongoing investments in transformation and rationalization efforts, including expense control and efficiency gains.

Balance Sheet and Cash Flow Overview

• Cash Position: \$12.4 million at year-end 2025, nearly unchanged from 2024.
• Total Assets: \$596.5 million at December 31, 2025, down from \$636.7 million a year earlier.
• Long-Term Debt: Increased to \$174 million in 2025 from \$147.3 million in 2024, reflecting the new term loans.
• Stockholders’ Equity: Declined to \$192.4 million from \$233.1 million, primarily due to net losses.
• Cash Flow from Operations: Negative \$21.2 million in 2025, compared to positive \$3.9 million in 2024.
• Cash Flow from Investing: Negative \$3.6 million, mainly due to capital expenditures.
• Cash Flow from Financing: Positive \$23.7 million due to net borrowings.

Details on Non-GAAP Measures

• Adjusted EBITDA Definition: Excludes non-recurring expenses, asset sale profits, transformation costs, asset impairments, product liability claims, and other one-time charges.
• GAAP vs. Non-GAAP: Management emphasizes that Adjusted EBITDA is not a substitute for GAAP measures, but is considered important for evaluating operational effectiveness and industry comparisons.
• No Reconciliation for Forward Guidance: Company states it cannot provide a full reconciliation for Adjusted EBITDA guidance due to unpredictability of excluded items.

Management Commentary

• CEO Dak Kaye: Highlights the pivotal nature of 2025, progress on business improvement, facility rationalization, and plans for growth with new products and improved margins.
• CFO David Johnson: Notes remediation of material weaknesses identified in the 2024 audit, improved gross profit margin and operating costs, and continued investment in business improvement actions.

Price-Sensitive Information for Shareholders

• Facility Rationalization: The decision to reduce activities at the Los Angeles facility is a major operational shift, likely impacting both short-term expenses and future efficiency.
• Headquarters Relocation: Cost savings expected from move, which may positively affect profitability.
• New Credit Facilities: Improved capital structure and liquidity, with extended maturities and balance sheet flexibility, should support strategic execution and growth.
• Remediation of Audit Weaknesses: The CFO confirmed all material weaknesses from the prior audit have been addressed, removing a key risk for investors.
• Personnel and Product Changes: Management changes and the launch of new products could drive future sales and margins.
• Improved Guidance: Management forecasts higher Adjusted EBITDA in 2026 (\$44-\$48 million vs. \$39.2 million in 2025), suggesting a positive outlook.

Conference Call and Additional Information

The company will host an earnings conference call on March 16, 2026, at 4:30 pm ET. A replay and supplementary presentation will be available on the Investor Relations section of American Vanguard’s website.

American Vanguard is a diversified specialty and agricultural products company, with over 1,000 product registrations worldwide, serving crop protection, turf, ornamentals, and public health markets.

Forward-Looking Statements and Risks

The report includes forward-looking statements regarding business improvements, product launches, operational efficiency, and financial performance. These statements are subject to risks and uncertainties detailed in SEC filings, and results may differ from management’s current expectations.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should review official filings and consult their financial advisors before making investment decisions. All forward-looking statements are subject to risks and uncertainties and may not materialize as described.

View AMERICAN VANGUARD CORP Historical chart here